Astroviruses cause 2-17 percent of the diarrhea episodes that require medical care in children. Our current understanding of the molecular epidemiology, seroprevalence, and immune response to astrovirus has been derived from limited studies from a variety of locations. Additional data are needed to determine if the prevention strategy of vaccine development is warranted. This study will describe attributes of human astroviruses (HAstVs) in two well-defined surveillance studies. The hypotheses of this study are that multiple HAstV antigenic types and strains are present simultaneously in a community, that type-specific immunity provides protection from symptomatic infection, and that HAstV illness results in an economic burden sufficient to warrant development and implementation of protective strategies.
The specific aims of this study are: 1) To characterize the antigenic and genetic diversity of HAstVs among children in two prospective surveillance studies including hospitalized children in three locations of the U.S. and children in Mexico City under a community-based surveillance. 2) To characterize the immune response to HAstV among naturally infected children from these populations by measuring type- specific anti-HAstV antibody. 3) To determine the role of serum antibody in protection of children from symptomatic infection, and to determine whether the protection is type-specific or group-specific. 4) To determine if the burden of disease is sufficient to develop a vaccine by evaluating the economic impact of severe HAstV diarrhea among children in three U.S. cities over two years of surveillance. Information regarding type variability, genomic variability, molecular epidemiology, and type-specific immune response to astrovirus are necessary to develop preventive measures including immunization strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI045872-01A1
Application #
6126573
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Everhart, James
Project Start
2000-09-01
Project End
2005-08-31
Budget Start
2000-09-01
Budget End
2001-08-31
Support Year
1
Fiscal Year
2000
Total Cost
$260,955
Indirect Cost
Name
Eastern Virginia Medical School
Department
Pediatrics
Type
Schools of Medicine
DUNS #
City
Norfolk
State
VA
Country
United States
Zip Code
23501
Nadan, S; Walter, J E; Grabow, W O K et al. (2003) Molecular characterization of astroviruses by reverse transcriptase PCR and sequence analysis: comparison of clinical and environmental isolates from South Africa. Appl Environ Microbiol 69:747-53
Walter, Jolan E; Mitchell, Douglas K (2003) Astrovirus infection in children. Curr Opin Infect Dis 16:247-53
Jakab, Ferenc; Walter, Jolan E; Berke, Tamas et al. (2003) Molecular characterization and sequence analysis of human astroviruses circulating in Hungary. FEMS Immunol Med Microbiol 39:97-102
Walter, J E; Briggs, J; Guerrero, M L et al. (2001) Molecular characterization of a novel recombinant strain of human astrovirus associated with gastroenteritis in children. Arch Virol 146:2357-67